| scholarly article | Q13442814 |
| P2093 | author name string | Franco Bertoni | |
| Eric L Staals | |||
| Patrizia Bacchini | |||
| P2860 | cites work | Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 de novo cases | Q35889280 |
| Dedifferentiated chondrosarcoma | Q40371639 | ||
| Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases | Q69541850 | ||
| Dedifferentiated chondrosarcoma: radiographic features | Q69628085 | ||
| Chondrosarcoma of bone with dedifferentiation: a study of eighteen cases | Q70338310 | ||
| Dedifferentiation of low-grade chondrosarcomas | Q71813557 | ||
| Experience in the treatment of dedifferentiated chondrosarcoma | Q73498630 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chondrosarcoma | Q1076087 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2682-2691 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Dedifferentiated central chondrosarcoma. | |
| P478 | volume | 106 |
| Q51781084 | 5'-methylschweinfurthin G reduces chondrosarcoma tumor growth . |
| Q51760341 | A case of dedifferentiated chondrosarcoma arising in the cricoid cartilage that mimicked an aneurysmal bone cyst. |
| Q51329500 | Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report. |
| Q89207211 | Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO) |
| Q90315302 | Coexistence of secondary chondrosarcoma and lung carcinoma metastasis in the humerus of a patient with Ollier's disease: A case report |
| Q34038664 | Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013. |
| Q37066573 | Consequences and prevention of inadvertent internal fixation of primary osseous sarcomas |
| Q41065859 | Dedifferentiated chondrosarcoma of the cervical spine: a case report. |
| Q39248894 | Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011). |
| Q36310646 | Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients |
| Q80676368 | Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases |
| Q36752695 | Dedifferentiated peripheral chondrosarcoma: a review of radiologic characteristics. |
| Q84522319 | Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes |
| Q39671725 | Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line |
| Q37563763 | Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? |
| Q33839039 | Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma |
| Q37251917 | Extended intralesional treatment versus resection of low-grade chondrosarcomas |
| Q44138085 | Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma |
| Q57022597 | H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features |
| Q38884358 | Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. |
| Q60934904 | MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis |
| Q38860922 | Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols |
| Q34182308 | NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine |
| Q40095575 | Possible prognostic role of IL-17R in osteosarcoma |
| Q38909468 | Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas |
| Q91755869 | Prognosis and treatment differences between initial and second primary chondrosarcoma |
| Q92504001 | Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution |
| Q92413707 | Radiologic differentiation of enchondromas, atypical cartilaginous tumors, and high-grade chondrosarcomas-Improving tumor-specific treatment: A paradigm in transit? |
| Q41855548 | Recent developments in the surgical treatment of bone tumors and their impact on quality of life |
| Q48017083 | SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours |
| Q34141410 | Secondary Chondrosarcoma |
| Q37185828 | Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells |
| Q43714147 | Survival analysis of patients with chondrosarcomas of the pelvis |
| Q37396044 | TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma |
| Q26774943 | The Identification of Prognostic Factors and Survival Statistics of Conventional Central Chondrosarcoma |
| Q38051004 | The imaging of cartilaginous bone tumours. II. Chondrosarcoma |
| Q37809576 | Therapeutic molecular targets in human chondrosarcoma |
| Q84318552 | [Dedifferentiated chondrosarcoma: radiologic-pathologic correlation] |
| Q84046021 | [Musculoskeletal tumors: significance of morphological diagnostics] |
Search more.